Skip to main content
Donate

Beth Phillips Synk

Beth Phillips Synk headshot
Beth Phillips Synk

Council Member

Communications Lead

Cigna

Specialties: Strategic communication, fundraising

Website

Imogen was born in 2021. When she was still not rolling over at nine months, her pediatrician referred her to neurology. This began a years-long journey to diagnosis.  

Imogen’s neurologist said she was likely just delayed. When she continued to fall further behind her peers, the family pushed for a referral to genetics. The tests came back normal, and Imogen was referred to a developmental pediatrician.  

This doctor suggested that because of her global delays, exceptionally happy demeanor, and love of water, Imogen may have Angelman Syndrome. This was the first the family had heard of it.  

After further testing, Imogen was diagnosed with mutation AS just before her third birthday. Despite her challenges, Imogen is the most determined, magical little girl. She inspires Beth to do as much as she can to help secure a brighter future for Immy and others like her.

Watch Beth's FAST Feature video.

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.